Approval · Notice of Compliance 10559 · 2009
RAN-CEFPROZIL: Notice of Compliance 10559
Issued September 1, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10559
- Date
- September 1, 2009
- Company
- Ranbaxy Pharmaceuticals Canada Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- New strength 125mg / 5ml
- Therapeutic class
- Antibiotic
- Canadian reference product
- CEFZIL (Bristol-Myers Squibb Canada)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RAN-CEFPROZIL | 02329204 | Marketed |
Medicinal ingredients
- CEFPROZIL MONOHYDRATE 125 MG per 5ML